
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


CME Group Inc (CME)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: CME (3-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $282.11
1 Year Target Price $282.11
4 | Strong Buy |
3 | Buy |
7 | Hold |
4 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 29.92% | Avg. Invested days 66 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 94.53B USD | Price to earnings Ratio 25.39 | 1Y Target Price 282.11 |
Price to earnings Ratio 25.39 | 1Y Target Price 282.11 | ||
Volume (30-day avg) 18 | Beta 0.44 | 52 Weeks Range 203.31 - 288.09 | Updated Date 09/14/2025 |
52 Weeks Range 203.31 - 288.09 | Updated Date 09/14/2025 | ||
Dividends yield (FY) 1.83% | Basic EPS (TTM) 10.33 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 58.59% | Operating Margin (TTM) 66.87% |
Management Effectiveness
Return on Assets (TTM) 1.74% | Return on Equity (TTM) 13.61% |
Valuation
Trailing PE 25.39 | Forward PE 22.52 | Enterprise Value 95849221211 | Price to Sales(TTM) 14.69 |
Enterprise Value 95849221211 | Price to Sales(TTM) 14.69 | ||
Enterprise Value to Revenue 14.87 | Enterprise Value to EBITDA 17.92 | Shares Outstanding 360376992 | Shares Floating 358787300 |
Shares Outstanding 360376992 | Shares Floating 358787300 | ||
Percent Insiders 0.44 | Percent Institutions 91.64 |
Upturn AI SWOT
CME Group Inc

Company Overview
History and Background
CME Group Inc. was founded in 1848 as the Chicago Board of Trade (CBOT). It merged with the Chicago Mercantile Exchange (CME) in 2007, creating CME Group. Throughout its history, it has pioneered financial derivatives, including futures and options, becoming a leading global derivatives marketplace.
Core Business Areas
- Derivatives Trading: CME Group provides a global platform for trading futures and options across various asset classes, including interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals.
- Clearing Services: CME Clearing provides clearing and settlement services for CME Group's exchanges and other trading venues, managing risk and ensuring the integrity of transactions.
- Data Services: CME Group offers market data services, providing real-time and historical data, analytics, and tools to market participants.
Leadership and Structure
CME Group is led by a CEO and a board of directors. The organizational structure includes various departments responsible for different business areas, such as trading, clearing, technology, and sales.
Top Products and Market Share
Key Offerings
- Interest Rate Products: CME Group is the world's leading interest rate derivatives marketplace. It offers contracts based on U.S. Treasury securities, Eurodollars, and other benchmark rates. They hold a significant portion of the market share and competitors include ICE and Eurex.
- Market Share (%): 60
- Equity Index Products: CME Group offers futures and options on major equity indexes such as the S&P 500, Nasdaq 100, and Dow Jones Industrial Average. Competitors include ICE and Eurex.
- Market Share (%): 45
- Agricultural Commodities: CME Group offers a wide range of agricultural futures and options contracts, including corn, soybeans, wheat, and livestock. Competitors include ICE.
- Market Share (%): 80
- Energy Products: CME Group provides a comprehensive suite of energy derivatives, including crude oil, natural gas, and refined products. Competitors include ICE.
- Market Share (%): 35
Market Dynamics
Industry Overview
The derivatives industry is characterized by increasing globalization, technological advancements, and regulatory changes. Demand for risk management tools and trading opportunities drives growth.
Positioning
CME Group is a dominant player in the global derivatives market, with a strong brand, extensive product portfolio, and advanced technology infrastructure. Its competitive advantages include network effects, clearing expertise, and regulatory compliance.
Total Addressable Market (TAM)
The global derivatives market is estimated to be worth trillions of dollars. CME Group is well positioned to capture a significant share of this market through its diverse product offerings and global reach.
Upturn SWOT Analysis
Strengths
- Strong Brand Reputation
- Global Reach
- Diverse Product Portfolio
- Advanced Technology Infrastructure
- Extensive Clearing Expertise
Weaknesses
- Dependence on Market Volatility
- Regulatory Scrutiny
- Technology Infrastructure Expenses
- Integration Risk from Acquisitions
Opportunities
- Expansion into New Markets
- Development of New Products
- Strategic Acquisitions
- Leveraging Technology for Innovation
- Increasing Demand for Risk Management Tools
Threats
- Increased Competition
- Regulatory Changes
- Economic Downturns
- Cybersecurity Risks
- Geopolitical Instability
Competitors and Market Share
Key Competitors
- ICE
- MKTX
- NDAQ
Competitive Landscape
CME Group's advantages include its strong brand, global reach, and diverse product portfolio. Its disadvantages include regulatory scrutiny and dependence on market volatility.
Major Acquisitions
NEX Group
- Year: 2018
- Acquisition Price (USD millions): 5500
- Strategic Rationale: Expanded CME Group's presence in fixed income and foreign exchange markets.
Growth Trajectory and Initiatives
Historical Growth: CME Group has experienced steady growth in revenue and earnings over the past decade, driven by increasing trading volumes and strategic acquisitions.
Future Projections: Analysts project continued growth for CME Group, driven by expansion into new markets, development of new products, and increasing demand for risk management solutions. Projected Revenue Growth 2024: 5%.
Recent Initiatives: Recent initiatives include expanding its product offerings in digital assets, investing in technology infrastructure, and pursuing strategic acquisitions.
Summary
CME Group is a strong company with a dominant position in the global derivatives market. Its diverse product portfolio and global reach are working well, driving revenue growth. However, regulatory scrutiny and dependence on market volatility remain key challenges to watch out for. Continued investment in technology and strategic acquisitions will be crucial for future growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- CME Group's Investor Relations
- SEC Filings
- MarketWatch
- Yahoo Finance
- Company Website
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered financial advice. Market conditions and company performance can change, and past results are not indicative of future performance.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CME Group Inc
Exchange NASDAQ | Headquaters Chicago, IL, United States | ||
IPO Launch date 2002-12-06 | Chairman & CEO Mr. Terrence A. Duffy | ||
Sector Financial Services | Industry Financial Data & Stock Exchanges | Full time employees 3760 | Website https://www.cmegroup.com |
Full time employees 3760 | Website https://www.cmegroup.com |
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.